Order Article Reprints

Wang J-S, Tsai P-H, Tseng K-F, Lin C-L, Chen F-Y, Chang C-T, Shen M-Y. Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients. Antioxidants. 2024; 13(12):1471. https://doi.org/10.3390/antiox13121471

Wang, Jie-Sian, Ping-Hsuan Tsai, Kuo-Feng Tseng, Cheng-Li Lin, Fang-Yu Chen, Chiz-Tzung Chang, and Ming-Yi Shen. 2024. "Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients" Antioxidants 13, no. 12: 1471. https://doi.org/10.3390/antiox13121471

Wang, J.-S., Tsai, P.-H., Tseng, K.-F., Lin, C.-L., Chen, F.-Y., Chang, C.-T., & Shen, M.-Y. (2024). Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients. Antioxidants, 13(12), 1471. https://doi.org/10.3390/antiox13121471